Unlikely to cause harm — often a labeling or packaging issue.
Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.
| Brand name | ALBUTEROL SULFATE |
| Generic name | ALBUTEROL SULFATE |
| Active ingredient(s) | ALBUTEROL SULFATE |
| Distributed by / for | Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-142-60 |
| Full product label | Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60. |
| Recalling firm | Cipla USA, Inc. |
| Distribution | U.S. Nationwide. |
| Quantity | 20352 packs (1x 200 MD) |
| Recall initiated | 2025-07-24 |
| Report date | 2025-08-27 |
| Recall completed | — |
| Recall number | D-0593-2025 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗